New Kinase Nomenclature Could Aid in Design of Cancer Drug Inhibitors
PHILADELPHIA (June 27, 2019) – Researchers at Fox Chase Cancer Center have developed a new classification scheme and nomenclature for the structural states of protein kinases, which play an important role in signaling pathways and can be targeted by cancer treatments.